In contrast, a threonine residue at position 877 would be extremely unfavorable for 9-fluorocortisol binding, and the hydrophobic leucine at position 701 in the wild-type receptor would be unable to engage in the formation of this stabilizing hydrogen bond network
: 3
Although we naturally produce this chemical, it decreases with age
,
Patil, S., Pimpley, V., Warudkar, K., & Murthy, P
The opportunities in these indications can be assessed by deploying effective new product planning / opportunity assessment methodologies, including evaluating the following for each potential indication: Level of in-class / competitive activity Likelihood of technical and regulatory success (i.e., based on scientific rationale and regulatory precedent) Level and nature of unmet needs for new therapies in the disease area of interest Potential for GLP1-s to address these unmet needs Commercial attractiveness of market Potential speed to market Alignment with individual manufacturer portfolio / strategy / capabilities Conclusion Incretin mimetics have had an immense and growing impact on patient outcomes